Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Josleyn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|July 30, 2013
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)Jay W Hooper, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 5, 2012
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)Rebecca Brocato, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 31, 2023
Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injectionAlexandra Jay, Steven A Kwilas, Matthew Josleyn, et al.
Current Gene Therapy|May 29, 2014
A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primatesSteve Kwilas, Jennifer M Kishimori, Matthew Josleyn, et al.
Plos One|August 4, 2012
Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primatesJoseph W Golden, Matthew Josleyn, Eric M Mucker, et al.
Physiological Genomics|April 5, 2007
The human reticulocyte transcriptomeSung-Ho Goh, Matthew Josleyn, Y Terry Lee, et al.
Vaccine|January 18, 2012
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndromeEllen F Boudreau, Matthew Josleyn, Diane Ullman, et al.
Mbio|September 11, 2024
Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human sourceRebecca L Brocato, Hua Wu, Steven A Kwilas, et al.
NPJ Vaccines|November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionJay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
Antiviral Research|September 13, 2017
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in miceDerek R Stein, Joseph W Golden, Bryan D Griffin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|July 30, 2013
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)Jay W Hooper, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 5, 2012
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)Rebecca Brocato, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 31, 2023
Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injectionAlexandra Jay, Steven A Kwilas, Matthew Josleyn, et al.
Current Gene Therapy|May 29, 2014
A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primatesSteve Kwilas, Jennifer M Kishimori, Matthew Josleyn, et al.
Plos One|August 4, 2012
Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primatesJoseph W Golden, Matthew Josleyn, Eric M Mucker, et al.
Physiological Genomics|April 5, 2007
The human reticulocyte transcriptomeSung-Ho Goh, Matthew Josleyn, Y Terry Lee, et al.
Vaccine|January 18, 2012
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndromeEllen F Boudreau, Matthew Josleyn, Diane Ullman, et al.
Mbio|September 11, 2024
Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human sourceRebecca L Brocato, Hua Wu, Steven A Kwilas, et al.
NPJ Vaccines|November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionJay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
Antiviral Research|September 13, 2017
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in miceDerek R Stein, Joseph W Golden, Bryan D Griffin, et al.
Pageof 1